Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Zhao, Huifang  [Clear All Filters]
Journal Article
Wang D, Du G, Chen X, Wang J, Liu K, Zhao H, Cheng C, He Y, Jing N, Xu P, et al. Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer. Cell Death Differ. 2024.
Huang Z, Li Z, Wang J, Gui R, Zu Y, Yu F, Lin Q, Zhao H, Zhang Y, Fang B, et al. A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy. Front Oncol. 2023;13:1162413.
He Y, Ji Z, Gong Y, Fan L, Xu P, Chen X, Miao J, Zhang K, Zhang W, Ma P, et al. Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation. Cell Rep. 2023;42(2):112033.
Liu K, Jing N, Wang D, Xu P, Wang J, Chen X, Cheng C, Xin Z, He Y, Zhao H, et al. A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour-immune cell communication. Cell Prolif. 2021:e13056.
Wang D, Cheng C, Chen X, Wang J, Liu K, Jing N, Xu P, Xi X, Sun Y, Ji Z, et al. IL-1β Is an Androgen-Responsive Target in Macrophages for Immunotherapy of Prostate Cancer. Adv Sci (Weinh). 2023:e2206889.
Tong Y, Wang F, Li S, Guo W, Li Q, Qian Y, Li L, Zhao H, Zhang Y, Gao W-Q, et al. Histone methyltransferase KMT5C drives liver cancer progression and directs therapeutic response to PARP inhibitors. Hepatology. 2023.
He L, Han X, Zhao H, Li S, Chen Z, Wang C, Wang S, Peng L, Deng W, Li Z, et al. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line (CSUXHi005-A) from human urine epithelial cells. Stem Cell Res. 2021;53:102289.
Zhao H, Li S, He L, Han X, Huang H, Tang F, Lin Z, Deng S, Tian C, Huang R, et al. Generation of iPSC line (USTCi001-A) from human skin fibroblasts of a patient with epilepsy. Stem Cell Res. 2020;45:101785.
Li S, Zhao H, Huang R, He L, Tian C, Huang H, Han X, Tang F, Lin Z, Deng S, et al. Generation of iPSC line (GIBHi001-A) from a patient with autism spectrum disorder. Stem Cell Res. 2019;40:101571.
He L, Zhao H, Li S, Han X, Chen Z, Wang C, Tian C, Tang F, Huang R, Lin Z, et al. Generation of induced pluripotent stem cell line (CSUXHi002-A) from a patient with spinocerebellar ataxia type 1. Stem Cell Res. 2020;45:101816.
Zhao H, He L, Li S, Huang H, Tang F, Han X, Lin Z, Tian C, Huang R, Zhou P, et al. Generation of corrected-hiPSC (USTCi001-A-1) from epilepsy patient iPSCs using TALEN-mediated editing of the SCN1A gene. Stem Cell Res. 2020;46:101864.
He L, Ye W, Chen Z, Wang C, Zhao H, Li S, Peng L, Han X, Zhou T, Li Z, et al. Generation of an induced pluripotent stem cell line (XHCSUi001-A) from urine cells of a patient with spinocerebellar ataxia type 3. Stem Cell Res. 2019;40:101555.
Zhao H, He L, Huang H, Li S, Cheng N, Tang F, Han X, Lin Z, Huang R, Zhou P, et al. Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing. Stem Cell Res. 2020;48:102003.
Wang X, Dong B, Zhang K, Ji Z, Cheng C, Zhao H, Sheng Y, Li X, Fan L, Xue W, et al. E-cadherin bridges cell polarity and spindle orientation to ensure prostate epithelial integrity and prevent carcinogenesis in vivo. PLoS Genet. 2018;14(8):e1007609.
He L, Ye W, Chen Z, Wang C, Zhao H, Li S, Peng L, Han X, Zhou T, Li Z, et al. Corrigendum to "Generation of an induced pluripotent stem cell line (XHCSUi001-A) from urine cells of a patient with spinocerebellar ataxia type 3" [Stem Cell Research Vol 40 (2019) 101555]. Stem Cell Res. 2020;43:101715.